Evaluation and Management of Nonculprit Lesions in STEMI

Research output: Contribution to journalReview article

Abstract

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.

Details

Authors
  • Troels Thim
  • Nina W. van der Hoeven
  • Carmine Musto
  • Robin Nijveldt
  • Matthias Götberg
  • Thomas Engstrøm
  • Pieter C. Smits
  • Keith G. Oldroyd
  • Anthony H. Gershlick
  • Javier Escaned
  • Sergio Bravo Baptista
  • Luis Raposo
  • Niels van Royen
  • Michael Maeng
Organisations
External organisations
  • Aarhus University Hospital
  • Amsterdam UMC - Vrije Universiteit Amsterdam
  • Azienda Ospedaliera San Camillo Forlanini
  • Radboud University Medical Center
  • Skåne University Hospital
  • University of Copenhagen
  • Golden Jubilee National Hospital
  • University of Leicester
  • Complutense University of Madrid
  • University of Lisbon
  • Maasstad Ziekenhuis
  • Centro Hospitalar de Lisboa Ocidental (CHLO)
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cardiac and Cardiovascular Systems

Keywords

  • CFR, FFR, iFR, nonculprit coronary lesions, STEMI
Original languageEnglish
Pages (from-to)1145-1154
Number of pages10
JournalJACC: Cardiovascular Interventions
Volume13
Issue number10
Publication statusPublished - 2020
Publication categoryResearch
Peer-reviewedYes